...
首页> 外文期刊>International journal of clinical oncology >Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer
【24h】

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer

机译:日本妇科肿瘤学会2015年指南,用于治疗包括原发性腹膜癌和输卵管癌在内的卵巢癌

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The fourth edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer was published in 2015. The guidelines contain seven chapters and six flow charts. The major changes in this new edition are as follows-(1) the format has been changed from reviews to clinical questions (CQ), and the guidelines for optimal clinical practice in Japan are now shown as 41 CQs and answers; (2) the 'flow charts' have been improved and placed near the beginning of the guidelines; (3) the 'basic points', including tumor staging, histological classification, surgical procedures, chemotherapy, and palliative care, are described before the chapter; (4) the FIGO surgical staging of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer was revised in 2014 and the guideline has been revised accordingly to take the updated version of this classification into account; (5) the procedures for examination and management of hereditary breast and ovarian cancer are described; (6) information on molecular targeting therapy has been added; (7) guidelines for the treatment of recurrent cancer based on tumor markers alone are described, as well as guidelines for providing hormone replacement therapy after treatment.
机译:日本妇科肿瘤学会第四版关于卵巢癌(包括原发性腹膜癌和输卵管癌)的治疗指南于2015年出版。该指南包含七章和六个流程图。该新版本的主要变化如下:(1)格式已从评论改为临床问题(CQ),现在,日本的最佳临床实践指南已显示为41个CQ和答案; (2)改进了“流程图”,并将其放置在准则的开头附近; (3)在本章之前介绍了“基本要点”,包括肿瘤分期,组织学分类,手术方法,化学疗法和姑息治疗。 (4)2014年对卵巢癌,输卵管癌和原发性腹膜癌的FIGO手术分期进行了修订,并对指南进行了相应修订,以考虑到该分类的更新版本; (5)描述了检查和处理遗传性乳腺癌和卵巢癌的程序; (6)增加了有关分子靶向治疗的信息; (7)描述了仅基于肿瘤标志物的复发性癌症治疗指南,以及治疗后提供激素替代治疗的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号